pindolol has been researched along with Neurally Mediated Faint in 4 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pindolol proved to be an effective treatment, even in patients who had previously failed treatment with conventional beta blockers, suggesting a clinical benefit from addition of ISA to beta blockade in this setting." | 2.69 | Usefulness of pindolol in neurocardiogenic syncope. ( Dutton, J; Iskos, D; Lurie, KG; Scheinman, MM, 1998) |
| "Pindolol was equally effective in men and women and the 2 age groups (>60 and <60 years) of the study cohort." | 1.32 | Usefulness of pindolol for treatment of neurocardiogenic syncope. ( Kantharia, BK; Kutalek, SP; Nair, N; Padder, FA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alegria, JR | 1 |
| Gersh, BJ | 1 |
| Scott, CG | 1 |
| Hodge, DO | 1 |
| Hammill, SC | 1 |
| Shen, WK | 1 |
| Nair, N | 1 |
| Padder, FA | 1 |
| Kutalek, SP | 1 |
| Kantharia, BK | 1 |
| Iskos, D | 1 |
| Dutton, J | 1 |
| Scheinman, MM | 1 |
| Lurie, KG | 1 |
| Cohen, TJ | 1 |
| Cayenne, S | 1 |
| Black, M | 1 |
| Doolittle, S | 1 |
| Ibrahim, B | 1 |
| Quan, W | 1 |
1 trial available for pindolol and Neurally Mediated Faint
| Article | Year |
|---|---|
Usefulness of pindolol in neurocardiogenic syncope.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middl | 1998 |
3 other studies available for pindolol and Neurally Mediated Faint
| Article | Year |
|---|---|
Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Comorbidity; Female; Humans; Male; Metoprolol; M | 2003 |
Usefulness of pindolol for treatment of neurocardiogenic syncope.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Blood Pressure | 2004 |
The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Female; Humans; Male; Metoprolol; Mi | 1999 |